Results 81 to 90 of about 5,102,595 (240)
Smaller is better: nanobodies meet NMR
FEBS Letters, EarlyView.Nanobodies are single‐domain antigen‐binding fragments derived from camelid heavy chain antibodies. Their small size, high stability, and exceptional specificity make nanobodies uniquely useful probes for NMR studies of protein dynamics, transient conformational states, and protein–protein interactions.
Oleg Y. Dmitriev
wiley +1 more source
Selector for the Spectrum Art Award 2018. Spectrum, London.
, 2018 Billingham was invited to be part of the selection panel for the first Spectrum Award in 2018 alongside Mark Wallinger, Charming Baker, Professor Simon Baron-Cohen, Sacha Craddock and Mary Simpson.
Billingham, R.
core +4 more sources
A spectral differential characterization of low-mass companions
EPJ Web of Conferences, 2013 We present a new approach with which the dynamical mass of low-mass companions around cool stars can be found. In order to discover companions to late-type stars the stellar spectrum is removed.
Lyubchik Y. +4 more
doaj +1 more source
FEBS Letters, EarlyView.Transient oligomers formed by intrinsically disordered proteins may be ‘invisible’ to direct detection yet remain accessible to solution NMR through equilibrium‐exchange measurements and pressure‐jump experiments. Complementary methods report on mass, stoichiometry, selected distance distributions, morphology, and internal packing.
Martin D. Gelenter, Ad Bax
wiley +1 more source
Mass spectrum of gapped, non-confining theories with multi-scale dynamics
Journal of High Energy Physics, 2019 We study the mass spectrum of spin-0 and spin-2 composite states in a one-parameter family of three-dimensional field theories by making use of their dual descriptions in terms of supergravity.
Daniel Elander +4 more
doaj +1 more source
A mass spectrum-oriented computational method for ion mobility-resolved untargeted metabolomics. [PDF]
Nat Commun, 2023 Luo M +6 more
europepmc +1 more source
Molecular Oncology, EarlyView.Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
When self-similarity meets mass spectrum and anisotropy
Astronomy & AstrophysicsContext. Self-similar evolution is widely used in the theory of collisional stellar dynamics, but its applicability to systems with multiple stellar masses is not well established. Aims.
Pavlík Václav
doaj +1 more source
Ultra-fast and accurate electron ionization mass spectrum matching for compound identification with million-scale in-silico library. [PDF]
Nat Commun, 2023 Yang Q +9 more
europepmc +1 more source
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source